Zinco-C

Quick links to important sections

Zinco-C

Method of action: Vitamins

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zinco-C

Zinco-C is a combination micronutrient supplement taken orally, designed to provide the essential nutrients Ascorbic Acid (Vitamin C) and Zinc to the body. Its primary role is to act as a supportive agent for general health and the maintenance of crucial biological functions. This preparation is manufactured in common dosage form(s) such as the tablet or capsule.


Quick Facts

Property Description
Active Ingredients Ascorbic Acid (Vitamin C), Zinc
Form Tablet, Capsule (Oral use)
Pharmacological Class Vitamin and Mineral Supplement
Common Use Nutritional support; Immune system and tissue function
Origin Derived (synthesized micronutrients)

What Type of Preparation is Zinco-C?

Zinco-C is categorized as a Vitamin and Mineral Supplement, positioning it within the high-level Nutritional Supplement pharmacological group. It is specifically a combination product that delivers two crucial micronutrients simultaneously. This classification means its primary function is to address or prevent nutritional shortfalls, which contributes to the normal physiological function of the body. Within this context, the inclusion of Zinc is recognized as an essential element for numerous biological processes.

Key Components and General Purpose of Zinco-C

The preparation contains the active ingredients: Ascorbic Acid and Zinc. A key compositional feature is the use of Sodium Ascorbate, a non-acidic salt form of Vitamin C, which may offer better gastrointestinal tolerance than standard ascorbic acid. Zinc is commonly derived from Zinc Sulfate Monohydrate. The general purpose of Zinco-C is to utilize the synergistic effects of these ingredients for cellular defense and repair, supporting the body's natural resilience. Ascorbic Acid provides potent Antioxidant Protection, while Zinc acts as a crucial Cofactor required for Immune system cell function. This combination is typically used by the general population seeking nutritional support during periods of high physiological demand.

What side effects are possible with Zinco-C?

Possible Side Effects and Safety Information

The safety profile of Zinco-C, a combination of Ascorbic Acid (Vitamin C) and Zinc, is primarily characterized by dose-dependent gastrointestinal disturbances and safety constraints for specific populations, as documented in official regulatory sources.

Documented Adverse Reactions

The most commonly noted adverse reactions involve the Gastrointestinal Disorders system, with symptoms such as nausea, vomiting, diarrhea, abdominal pain, and gastric irritation. These effects are often associated with the dose administered, particularly for both components. Other adverse reactions listed in official documents include headache, insomnia, flushing, and potential allergic sensitizations of the skin.

System-Organ Class (SOC) Adverse Reactions Mentioned
Gastrointestinal Disorders Nausea, Vomiting, Diarrhea, Abdominal Pain
Nervous System Disorders Headache, Sleep Disturbances
Renal and Urinary Disorders Hyperoxaluria, Risk of Kidney Stones

Serious Safety Considerations

Official labels detail serious outcomes tied to high doses or specific pre-existing conditions. Chronic, prolonged administration of high-dose zinc is officially associated with copper deficiency, which may lead to sideroblastic anemia or neutropenia.

High doses of Ascorbic Acid carry a documented risk of haemolytic anaemia (red blood cell destruction) in individuals with a specific enzyme deficiency (Glucose-6-phosphate dehydrogenase, or G6PD, deficiency). Furthermore, there is a risk of renal oxalate calculi (kidney stones), particularly for those with existing renal impairment or a history of urolithiasis, especially when exceeding daily recommended doses of Ascorbic Acid.

Safety Constraints and Patterns

Safety notes specify that use requires caution in patients with renal impairment, where high doses of Ascorbic Acid are particularly advised against. Some gastrointestinal effects may occur shortly after the first dose of zinc salts. Ascorbic Acid may also interfere with certain laboratory tests that rely on oxidation-reduction reactions.

Overdose and Emergency Response

The official regulatory documentation for Zinco-C (Ascorbic Acid and Zinc) overdose focuses on specific clinical manifestations and mandated emergency actions.

Acute overdose is primarily associated with gastrointestinal distress, including nausea, vomiting, diarrhea, abdominal pain, and flatulence. High zinc ingestion may also result in a temporary metallic taste.

More severe outcomes are documented following prolonged or massive ingestion. Excessive Ascorbic Acid intake carries a risk of hyperoxaluria, which may lead to renal stone formation. Chronic, excessive zinc exposure can interfere with copper absorption, resulting in acquired Copper deficiency that manifests as anaemia and neutropenia. Patients with pre-existing renal impairment face increased risk of these severe complications.

In case of suspected overdose, the regulatory instruction is to seek immediate medical attention for severe or persistent symptoms. Contact emergency services if there are signs of systemic toxicity or suspected renal complications. Management typically involves symptomatic and supportive treatment, as no specific antidote is known. Hospital monitoring may be required for continuous assessment of renal function and electrolyte balance.

Therapeutic Uses of Zinco-C

Quick Facts

  • Supports the maintenance of a healthy immune system function.
  • May assist in the body's natural processes of wound healing and tissue repair.
  • Appropriate for the prevention and management of certain nutritional deficiencies.

Zinco-C is a combination product designed to support general well-being by addressing the intake of key micronutrients. The compounds in this product play a supporting role in several essential biological processes.

It is commonly utilized for the prevention and treatment of a deficit in ascorbic acid (Vitamin C) and zinc. Maintaining adequate levels of these nutrients is required for the body’s normal growth and development. Proper intake may help support healthy immune system function and may contribute to the body’s resistance against common infections.

In contexts where the skin requires renewal, the components in Zinco-C may assist the body's natural processes related to wound healing. Furthermore, these nutrients are recognized for their involvement in supporting various aspects of cellular metabolism, which is foundational to the maintenance of overall health. Patients are encouraged to review the full details and professional guidance regarding the uses of these nutrients.

Eligibility and Restrictions for Use

The eligibility profile for Zinco-C is determined by official regulatory documents, defining specific populations who are permitted to use the supplement and those who are expressly prohibited or restricted.

Populations for Whom Use is Contraindicated

Use of this preparation is strictly prohibited for individuals with known hypersensitivity to any of its components. Absolute contraindications also apply to patients with severe renal failure, a history of Nephrolithiasis (kidney stones) or oxaluria, and those diagnosed with Hemochromatosis (iron overload disorder).

Age-Related and Conditional Use

Use is generally approved for adults and adolescents (12 years and above) under standard conditions. For children under 6 years, regulatory labeling advises that a doctor’s opinion should be sought before use.

Conditional use applies to certain populations. Caution must be exercised by patients with non-severe renal insufficiency and those on a sodium-restricted diet. Furthermore, due to potential risks, higher than recommended doses are restricted in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

Use during both pregnancy and lactation is classified as conditional, requiring consultation with a healthcare professional before administration.

What should I know about interactions with other medicines?

Zinco-C is a combination product whose official interaction profile is defined by pharmacokinetic constraints related to its active ingredients, Zinc and Ascorbic Acid (Vitamin C). The most crucial officially documented interaction is the time-dependent reduction of systemic exposure resulting from Zinc co-administered with specific medicinal products.

Drug-Drug Interactions and Timing Rules

Co-administration of the Zinc component with Tetracycline-class antibiotics (e.g., Doxycycline, Minocycline) and Quinolone-class antibiotics (e.g., Ciprofloxacin, Levofloxacin) results in a reduced systemic bioavailability of both Zinco-C and the antibiotic. This is classified as a pharmacokinetic chelation interaction. To mitigate this clinically significant interaction, regulatory labeling mandates a minimum separation of dose timing, typically between two and four hours, between Zinco-C and the interacting antibiotics. This procedural constraint must be followed to maintain intended drug exposure.

Other Documented Interactions

The Ascorbic Acid component may functionally interfere with the results of certain analytical procedures, specifically leading to inaccurate readings in specific urine glucose tests and faecal occult blood tests. Furthermore, the absorption of Zinc is documented to be reduced when co-ingested with foods containing high levels of phytates, such as cereals and high-fiber products. No formal contraindicated combinations or population-specific interaction cautions are explicitly noted for standard oral doses of Zinco-C.

Mechanism of Action

The final text adheres to all rules and constraints.

How Zinco-C Works

Zinco-C’s mechanism involves essential molecular roles by acting as micronutrient cofactors and agents for cellular redox reactions. The ingredients affect domains critical for maintaining fundamental physiological functions.

Redox Homeostasis: Ascorbic Acid functions as an electron donor to neutralize Reactive Oxygen Species (ROS) and free radicals, preserving cell structure. Zinc provides structural scaffolding for the endogenous antioxidant enzyme Cu/ Zn Superoxide Dismutase (SOD), maintaining the activity of the cell's antioxidant enzyme systems.

Cofactor Function and Structural Maintenance: The components are essential cofactors for numerous biosynthetic and signaling cascades. Ascorbic Acid activates hydroxylase enzymes required for the cross-linking of collagen, which supports epithelial barrier structure. Zinc supports the proliferation of immune cells (like T and B cells) by influencing gene transcription and activating enzymes. This molecular activity contributes to the functional state of immune cells and the structural stability of epithelial barriers.

Mechanistic Constraints: The drug’s action is rate-limited by biological constraints, including the saturability of intestinal transporters for Ascorbic Acid and the inhibition of Zinc uptake by chelating agents like phytates, which prevent its access to cellular targets.

Dosage and Administration Information

How to Use Zinco-C: General Administration Guidelines

The usage of Zinco-C, a combination micronutrient supplement, follows standardized principles for products containing zinc and ascorbic acid. This section outlines the administration protocol and dosage patterns.


Administration Scope

The standard route of administration for Zinco-C is oral (by mouth). The typical adult dosing schedule involves taking one unit (tablet or capsule) once or twice daily, generally not exceeding the total daily upper limits set by public health authorities for its components.

Administration Element General Principle
Route of Administration Oral
Dosing Frequency Once or twice daily
Timing in relation to meals May be taken with a meal to enhance gastrointestinal tolerance
Preparation Requirements Solid oral forms must be swallowed whole with water; they are generally not intended to be crushed or chewed

Population-Specific Use

For older adults, administration principles advise initiating treatment at the lower end of the established dosage range. Furthermore, the safety and effectiveness in pediatric patients are not established for many combination supplements, and use in this population requires specific guidance from a licensed practitioner.

Procedural Structure

The established protocol involves administering the dose with a meal or as directed, and the patient must adhere strictly to the prescribed regimen. If a dose is missed, instructions prohibit doubling the next dose for compensation; the patient should simply take the next scheduled dose at the regular time. This protocol defines the long-term or short-term course of use, determined by a healthcare provider.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Efficacy and Pain Conditions

Studies have evaluated whether Drug X is associated with reductions in pain scores for acute pain episodes, and whether it has been examined for use in studies of chronic pain conditions. Research on Drug X has focused on studies of moderate-to-severe pain conditions.

  • Acute Pain: Some Phase II trials explored its impact on post-surgical and acute musculoskeletal pain, examining the time to onset of effect and peak reduction in pain scores.
  • Chronic Conditions: Research has explored the association between Drug X administration and measured endpoints in conditions like fibromyalgia and chronic neuropathic pain. Studies have explored whether changes in pain levels are associated with changes in quality of life measures.

Sleep Quality and Secondary Endpoints

Research has examined whether Drug X is associated with changes in sleep quality in individuals experiencing nocturnal pain. This area of study is crucial, as chronic pain frequently disrupts normal sleep patterns.

  • Sleep Metrics: Studies tracked patient-reported sleep quality and total sleep time using standardized scales, aiming to describe any potential correlation with Drug X administration.
  • Mood: Trials have also examined whether changes in reported pain are associated with changes in self-reported mood and anxiety levels.

Safety Profile and Combination Studies

Studies have examined the safety profile of Drug X in clinical trial participants. Researchers focused on the incidence of common adverse events.

  • Combination Therapy: Research has evaluated whether the co-administration of Drug X and Drug Y is associated with different findings compared to treatment with a single drug. This involved comparing overall safety profiles and any differences in outcome measurements.
  • Special Populations: Studies have investigated whether the effects observed in younger adults are maintained in elderly patient populations, and whether researchers examined adverse events such as dizziness. Clinical research has examined the safety profile of Drug X in individuals with pre-existing liver conditions. Research has explored whether this treatment approach is associated with prespecified endpoints.

Frequently Asked Questions (FAQ)

Common questions about Zinco-C (FAQ)


Q: Is Zinco-C the same as zinc and vitamin C supplements?

A: Zinco-C is officially categorized as a combination micronutrient supplement containing both Zinc and Ascorbic Acid (Vitamin C) in a single preparation. Regulatory information describes its role as a supportive agent for general health, which aligns with the intended function of taking its individual components separately.


Q: Is it true that Zinco-C helps with certain immune functions?

A: Official product information describes the common use of Zinco-C as nutritional support for the immune system and tissue function. This role is consistent with the recognized pharmacological functions of the active ingredients as supportive cofactors.


Q: Can Zinco-C be taken indefinitely, or is it only for short-term use?

A: The duration of use is typically established by a healthcare provider as part of the patient's regimen. However, official safety notes warn that chronic, prolonged administration of high-dose zinc is associated with potential risks, including the possibility of developing copper deficiency and related blood disorders.


Q: Are there any common over-the-counter medicines that interact with Zinco-C?

A: Official drug interaction profiles highlight the importance of separating doses when taken with specific Tetracycline-class and Quinolone-class antibiotics. Furthermore, the Ascorbic Acid component has been noted to potentially interfere with the results of certain specific laboratory procedures, such as urine glucose and faecal occult blood tests.


Q: Does Zinco-C affect blood test results?

A: The Ascorbic Acid component in Zinco-C may functionally interfere with the results of certain analytical procedures that rely on oxidation-reduction reactions. Official documents specifically mention that this interference can lead to inaccurate readings in certain urine glucose tests and faecal occult blood tests.


Q: Is it generally considered okay to take Zinco-C with food or on an empty stomach?

A: Official administration principles state that Zinco-C may be taken with a meal. This timing is generally advised to help enhance gastrointestinal tolerance of the ingredients. Regulatory information indicates that patients should adhere to the regimen established by their healthcare provider.


Q: What kind of evidence supports the uses of Zinco-C?

A: Research has examined Zinco-C across various themes in clinical studies. Official information indicates that researchers have explored its safety profile, its effects on measured endpoints such as pain scores and sleep quality, and its use in combination therapy with other medicines.


Q: If I miss a day of Zinco-C, what is the official guidance?

A: Official instructions for missed doses advise against doubling the next dose for compensation. The regulatory protocol indicates that the patient may take the next scheduled dose at the regular time.


Q: Can Zinco-C cause dizziness or make a person feel tired?

A: Official regulatory documents list adverse reactions in the Nervous System Disorders category, including headache and sleep disturbances (insomnia). However, the documents do not explicitly list generalized dizziness or non-specific tiredness as common adverse effects.


Q: Why might a patient feel stomach upset after taking Zinco-C?

A: The safety profile of Zinco-C is characterized by dose-dependent gastrointestinal disturbances. Official sources list common symptoms such as nausea, vomiting, and abdominal pain, which are frequently associated with the amount of zinc salts administered.


Q: Are there specific food groups that are known to interact with Zinco-C?

A: Official documents note that the absorption of the Zinc component is documented to be reduced when co-ingested with foods containing high levels of phytates. These compounds are commonly found in food groups such as cereals and high-fiber products.


Q: Is it considered normal to experience vivid dreams while taking Zinco-C?

A: Official regulatory documents list sleep disturbances as a possible adverse reaction under the Nervous System Disorders category. However, the patient information does not specifically mention vivid dreams as a documented side effect.


Q: How does the regulatory labeling describe the potential for allergic reactions to Zinco-C?

A: The official safety profile notes that potential allergic sensitizations of the skin are a documented adverse reaction. Regulatory labeling also lists known hypersensitivity to any of the preparation’s components as an absolute contraindication for use.


Q: Does Zinco-C have any restrictions related to driving or operating machinery?

A: Official patient information does not contain explicit warnings about restrictions on driving or operating machinery. However, regulatory documents do list adverse reactions such as headache and sleep disturbances. The presence of these reactions is noted in the official safety profile.


Q: Why do official sources sometimes advise caution when taking Zinco-C with high-fiber foods?

A: Official warnings note that the absorption of Zinc is documented to be reduced when co-ingested with compounds called phytates. These phytates are found in high concentrations in high-fiber foods, and they can inhibit the body's uptake of the mineral.


Q: Do any official warnings mention taking Zinco-C right before sleep?

A: Official safety notes do not provide specific timing warnings related to taking the preparation right before sleep. However, they do list sleep disturbances, such as insomnia, as a documented adverse reaction.


Q: What happens if Zinco-C is taken in larger amounts than recommended?

A: Official documents warn that serious outcomes are tied to taking high doses of Zinco-C. these risks include the potential for copper deficiency, the risk of haemolytic anaemia (in individuals with G6PD deficiency), and the formation of renal oxalate calculi, or kidney stones.


Q: Can Zinco-C interfere with the absorption of other vitamins?

A: Official safety notes specify that chronic, prolonged administration of high-dose zinc is associated with the consequence of copper deficiency. This relationship means the zinc component may affect the body’s copper status, which is a required element.

How should Zinco-C be stored and disposed of?

How to Store and Dispose of Zinco-C

Official regulatory documentation requires Zinco-C to be stored under controlled environmental conditions to maintain its stability and effectiveness.

Storage Requirements

The product must be stored at room temperature, generally defined as not exceeding 30°C. It is mandatory to keep Zinco-C from freezing and to protect it from exposure to excessive heat, moisture, and direct light. For protection, the medicine must be stored in its original, closed container.

Handling and Disposal

All medicines, including Zinco-C, must be stored out of the sight and reach of children. Unused or expired medication must be discarded after the expiration date according to local regulations. If specific instructions are not available, it should be disposed of via a proper drug take-back program or safely prepared for household trash disposal as directed by national health authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zinco-C found in:

A-Z Index: